CMS Open Payments · Program Year 2024
Lumendi LLC
Lumendi LLC reported $164,578.94 across General Payments, Research, and Ownership to 83 physicians and teaching hospitals across 83 transactions.
- $164.6K Below-median payer
- All-tracks total
- 83 Below-median volume
- Transactions
- 83 Below-median reach
- Recipients
- +$41.9K
- General Payments vs PY2023
Lumendi LLC reported $164,578.94 across all CMS Open Payments tracks (General + Research + Ownership) to 83 physicians and teaching hospitals in Program Year 2024 - ranking #1059 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $164,578.94, averaging $2.0K per recipient.
Lumendi LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lumendi-llc Lumendi LLC
$164.6K · #1059/1,925 · 0.0% industry · PY2024
- TOT $164.6K
- RANK #1059
- SHARE 0.0%
- TXN 83
- RCP 83
- CAT 5
- GEN $164.6K
- ΔGEN +$41.9K
- TOP1 34.7%
- PY 2024
Volume peers
Nearest volume peer: Resmed Corp ($164.6K)
Lumendi LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lumendi LLC's CMS-reported General Payments increased by $41.9K (+34.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LUMENDI LLCPY2023: LUMENDI LLCPY2024: LUMENDI LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $122,661.00
- PY2024
- $164,578.94
What the Data Shows for Lumendi LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Lumendi LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $138.4K, accounting for 84.1% of this company's General Payments and 36 transactions.
General Payment Breakdown by Type
Lumendi LLC made 5 types of general payments. "Consulting Fee" is the largest category at $138.4K, 84.1% of General Payments.
Lumendi LLC reports 5 general-payment categories - the top three are Consulting Fee (84.1%), Travel and Lodging (6.7%), and Compensation for Services Other Than Consulting (4.4%). The remaining 2 categories make up 4.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Lumendi LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $138.4K | 36 | 84.1% |
| Travel and Lodging | $11.0K | 16 | 6.7% |
| Compensation for Services Other Than Consulting | $7.3K | 3 | 4.4% |
| Space Rental or Facility Fees | $6.0K | 1 | 3.6% |
| Food and Beverage | $1.9K | 27 | 1.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $133,471.52 (81.1%) of $164,578.94 in this company's General Payments records across 30 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lumendi LLC
The five named recipients with the highest reported General Payments from this company
- 1
Sergey Kantsevoy
$57,077.62 across 14 reported transactions
- 2
Ihya E Gorgun
$56,395.50 across 13 reported transactions
- 3
Molham Abdulsamad
$8,186.09 across 5 reported transactions
- 4
Adventhealth Orlando
$6,000.00 across 1 reported transactions
- 5
Ovunc Bardakcioglu
$5,812.31 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lumendi LLC ranks #1059 of 1,925 by total payments (bottom 45% by spend) but is notably more concentrated than that alone would suggest -- #657 of 1,838 by HHI (top 36% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Civica, Inc. : $1.1K total payments, HHI 2493
- Atlas Spine, Inc. : $31.3K total payments, HHI 2488
- Agfa HealthCare Corporation : $400.9K total payments, HHI 2487
- Zap Surgical Systems, Inc. : $43.0K total payments, HHI 2486
- VisionRT, Inc. : $6.9K total payments, HHI 2476
- Ventana Medical Systems, Inc. : $655.4K total payments, HHI 2476
- Lumendi LLC (this company) : $164.6K total payments, HHI 2475
- Shalby Advanced Technologies, Inc. : $120.5K total payments, HHI 2474
- Meitheal Pharmaceuticals, Inc. : $3.3K total payments, HHI 2461
- Naviswiss, Inc. : $48.9K total payments, HHI 2455
- ParaPRO, LLC : $38.8K total payments, HHI 2454
- The Binding Site Inc. : $5.0K total payments, HHI 2452
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lumendi LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lumendi LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lumendi LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
BK Medical Holding Company Inc.
Gotham Surgical Solutions & Devices, Inc.
SweetBio, Inc.
Avertix Medical, Inc
B. Braun Melsungen AG
Put this to use
Lumendi LLC ranks #1059 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Lumendi LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.